Because impaired GLP-1 responses might be partly responsible for the impaired incretin effect in people with T2DM, this was an important observation, but other most often smaller studies did not confirm the impaired secretion and meta-analyses have not been able to conclude that impaired secretion is a general finding (44, 45). The gene discussed is GCG; the disease is type 2 diabetes mellitus.